Net sales and EBITA
Net sales by business area
| Q3 | Q3 | ∆ | Jan-Sep | Jan-Sep | ∆ | Oct 2025- | Full year | |
| SEKm | 2026 | 2025 | % | 2026 | 2025 | % | Sep 2026 | 2025 |
| Labtech | 983 | 906 | 8 | 3,025 | 2,880 | 5 | 4,098 | 3,953 |
| Medtech | 1,617 | 1,524 | 6 | 4,944 | 4,832 | 2 | 6,607 | 6,495 |
| Group items | -1 | -1 | -4 | -3 | -7 | -6 | ||
| The Group | 2,599 | 2,429 | 7 | 7,965 | 7,709 | 3 | 10,698 | 10,442 |
EBITA / EBITA margin by business area and operating profit for the Group
| Q3 | Q3 | Jan-Sep | Jan-Sep | Oct 2025- | Full year | |
| SEKm | 2026 | 2025 | 2026 | 2025 | Sep 2026 | 2025 |
| Labtech | 115 | 102 | 386 | 343 | 538 | 495 |
| Medtech | 226 | 177 | 651 | 607 | 1,008 | 964 |
| Group items | -11 | -9 | -33 | -30 | -45 | -42 |
| EBITA | 330 | 270 | 1,004 | 920 | 1,501 | 1,417 |
| Depreciation and write-down intangible assets | -109 | -105 | -318 | -320 | -422 | -424 |
| Operating profit | 221 | 165 | 686 | 600 | 1,079 | 993 |
| Finance income and expenses | -42 | -54 | -135 | -171 | -185 | -221 |
| Profit after financial items | 179 | 111 | 551 | 429 | 894 | 772 |
| | ||||||
| Q3 | Q3 | Jan-Sep | Jan-Sep | Oct 2025- | Full year | |
| % | 2026 | 2025 | 2026 | 2025 | Sep 2026 | 2025 |
| Labtech | 11.7 | 11.2 | 12.8 | 11.9 | 13.1 | 12.5 |
| Medtech | 14.0 | 11.6 | 13.2 | 12.6 | 15.3 | 14.8 |
| EBITA margin | 12.7 | 11.1 | 12.6 | 11.9 | 14.0 | 13.6 |
| Operating margin | 8.5 | 6.8 | 8.6 | 7.8 | 10.1 | 9.5 |
Net sales by revenue type
| Q3 | Q3 | Jan-Sep | Jan-Sep | Oct 2025- | Full year | |
| SEKm | 2026 | 2025 | 2026 | 2025 | Sep 2026 | 2025 |
| Products | 681 | 631 | 2,148 | 2,066 | 2,877 | 2,795 |
| Instruments | 218 | 189 | 633 | 579 | 898 | 844 |
| Services | 84 | 86 | 244 | 235 | 323 | 314 |
| Labtech | 983 | 906 | 3,025 | 2,880 | 4,098 | 3,953 |
| Products | 1,338 | 1,258 | 4,111 | 3,974 | 5,499 | 5,362 |
| Instruments | 115 | 102 | 349 | 377 | 465 | 493 |
| Services | 164 | 164 | 484 | 481 | 643 | 640 |
| Medtech | 1,617 | 1,524 | 4,944 | 4,832 | 6,607 | 6,495 |
| Group items | -1 | -1 | -4 | -3 | -7 | -6 |
| The Group | 2,599 | 2,429 | 7,965 | 7,709 | 10,698 | 10,442 |
Sales per country
| Q3 | Q3 | Jan-Sep | Jan-Sep | Oct 2025- | Full year | |
| SEKm | 2026 | 2025 | 2026 | 2025 | Sep 2026 | 2025 |
| Ireland | 352 | 328 | 1,009 | 996 | 1,343 | 1,330 |
| Sweden | 306 | 299 | 966 | 896 | 1,296 | 1,226 |
| UK | 320 | 290 | 933 | 945 | 1,238 | 1,250 |
| Spain | 231 | 235 | 805 | 799 | 1,084 | 1,078 |
| Norway | 179 | 178 | 622 | 629 | 821 | 828 |
| Denmark | 163 | 157 | 511 | 489 | 703 | 681 |
| Italy | 141 | 170 | 510 | 563 | 678 | 731 |
| Finland | 145 | 129 | 436 | 397 | 595 | 556 |
| Germany | 127 | 114 | 362 | 339 | 478 | 455 |
| Switzerland | 98 | 87 | 310 | 289 | 401 | 380 |
| Rest of Europe | 513 | 393 | 1,312 | 1,143 | 1,870 | 1,701 |
| Rest of the World | 24 | 49 | 189 | 224 | 191 | 226 |
| Total | 2,599 | 2,429 | 7,965 | 7,709 | 10,698 | 10,442 |